|
|
Article: Hepatitis C Virus-Associated Malignant Transformation in Liver Produces a Cytotoxic Antimalignin Antibody Immune Response Which Can Be Augmented by a Synthetic Vaccine.
- Article from:
- Vaccine Weekly
- Article date:
- December 21, 1998
CopyrightCOPYRIGHT 1998 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"Hepatitis C Virus-Associated Malignant Transformation in Liver Produces a Cytotoxic Antimalignin Antibody Immune Response Which Can Be Augmented by a Synthetic Vaccine." S. Bogoch and E.S. Bogoch. Foundation for Research on the Nervous System and Oncolab, The Fenway, Boston. Massachusetts.
According to an abstract submitted by the authors to the Cellular Targets of Viral Carcinogenesis conference, a special conference in cancer research sponsored by the American Association for Cancer Research, held September 24-28, 1998, in Dana Point, California, "Carcinogenesis in the liver is an established consequence of Hepatitis C virus (HCV) infection in humans, but ...